CN Patent

CN117813083A — 维持抑郁症状缓解的方法

Assigned to Antecip Bioventures II LLC · Expires 2024-04-02 · 2y expired

What this patent protects

本文公开了使用安非他酮和右美沙芬的组合治疗诸如抑郁症的神经或精神疾病或病症的方法。还描述了相关的组合物和剂型。

USPTO Abstract

本文公开了使用安非他酮和右美沙芬的组合治疗诸如抑郁症的神经或精神疾病或病症的方法。还描述了相关的组合物和剂型。

Drugs covered by this patent

Patent Metadata

Patent number: CN117813083A
Jurisdiction: CN
Classification: —
Expires: 2024-04-02
Drug substance claim: No
Drug product claim: No
Assignee: Antecip Bioventures II LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.